γc-cytokines in HIV Cure Research

Area of Science:

• Immunology
• Virology
• Therapeutics

Background:

• Latent HIV reservoirs are a major barrier to a global HIV cure.
• Common gamma-chain cytokines (γc-cytokines) are being explored for their potential in HIV cure strategies.
• These cytokines possess both latency-reversing and immunomodulatory properties.

Purpose of the Study:

• To review recent in vitro, ex vivo, and in vivo studies on the use of γc-cytokines in HIV cure research.
• To evaluate the efficacy of γc-cytokines as standalone or combination therapies.
• To assess the potential of γc-cytokines in targeting latent HIV reservoirs.

Main Methods:

• Review of in vitro, ex vivo, and in vivo studies.
• Analysis of γc-cytokine activity, including IL-2 and IL-15 (N-803).
• Evaluation of combination therapies with broadly neutralizing antibodies and other interventions.

Main Results:

• γc-cytokines, particularly IL-15/N-803, effectively reactivate latent HIV, especially with STAT-dependent transcriptional enhancement.
• IL-15-based therapies combined with broadly neutralizing antibodies show potential for viral control in vivo.
• IL-15/N-803 enhances HIV-specific immunity by promoting NK and CD8+ T cell survival, proliferation, and function.

Conclusions:

• γc-cytokines act as dual-function agents, reversing HIV latency and enhancing immune responses.
• Preclinical and clinical data support integrating γc-cytokines into multi-pronged HIV cure strategies.
• These cytokines lay the groundwork for developing durable, functional HIV cure approaches.